Detection of serum p53 protein in patients with different gastrointestinal cancers

被引:37
作者
Attallah, AM
Abdel-Aziz, MM
El-Sayed, AM
Tabll, AA
机构
[1] Biotechnol Res Ctr, New Damietta, Egypt
[2] Mansoura Univ, Gastroenterol & Surg Ctr, Res Labs Dept, Mansoura, Egypt
来源
CANCER DETECTION AND PREVENTION | 2003年 / 27卷 / 02期
关键词
p53; serum; gastrointestinal; cancer; monoclonal antibody; polyclonal antibody;
D O I
10.1016/S0361-090X(03)00024-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Overexpression of p53 has been found in many types of human malignancy. The present study aimed to detect preoperative serum p53 among 158 patients with different gastrointestinal cancers using ELISA technique based on mouse anti-p53 DO-7 monoclonal antibody and anti-p53 rabbit polyclonal antibody. A single band of 53 kDa was detected in nuclear protein tissue extracts of selected cancer patients and in 96% of the corresponding sera using Western blot assay. The ELISA technique revealed that the serum p53 was detected in 100% of patients with cholangiocarcinoma, 76% of pancreatic carcinoma, 75% of hepatocellular carcinoma, 70% of colon cancer, 60% of esophagus carcinoma, and 35% of gastric carcinoma. The serum p53 concentrations of the positive patients were highly elevated (P < 0.001) compared with healthy individuals. These results suggest that immunodetection of serum p53 could be valuable for post-operative monitoring during follow up in preoperatively positive patients with gastrointestinal cancers. (C) 2003 International Society for Preventive Oncology. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:127 / 131
页数:5
相关论文
共 33 条
[1]  
Aizawa K, 1999, INT J ONCOL, V14, P85
[2]  
Angelopoulou K, 1997, INT J CANCER, V70, P46, DOI 10.1002/(SICI)1097-0215(19970106)70:1<46::AID-IJC7>3.0.CO
[3]  
2-6
[4]  
Attallah AM, 1997, HEPATO-GASTROENTEROL, V44, P1595
[5]   Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue [J].
Barshack, I ;
Goldberg, I ;
Chowers, Y ;
Weiss, B ;
Horowitz, A ;
Kopolovic, J .
JOURNAL OF CLINICAL PATHOLOGY, 2001, 54 (09) :684-688
[6]   Conformational effects in the p53 protein of mutations induced during chemical carcinogenesis: Molecular dynamic and immunologic analyses [J].
BrandtRauf, PW ;
Chen, JM ;
Marion, MJ ;
Smith, SJ ;
Luo, JC ;
Carney, W ;
Pincus, MR .
JOURNAL OF PROTEIN CHEMISTRY, 1996, 15 (04) :367-375
[7]   Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis [J].
Cawley, HM ;
Meltzer, SJ ;
De Benedetti, VMG ;
Hollstein, MC ;
Muehlbauer, KR ;
Liang, L ;
Bennett, WP ;
Souza, RF ;
Greenwald, BD ;
Cottrell, J ;
Salabes, A ;
Bartsch, H ;
Trivers, GE .
GASTROENTEROLOGY, 1998, 115 (01) :19-27
[8]   DETECTION OF ANTIBODIES AGAINST THE CELLULAR PROTEIN P53 IN SERA FROM PATIENTS WITH BREAST-CANCER [J].
CRAWFORD, LV ;
PIM, DC ;
BULBROOK, RD .
INTERNATIONAL JOURNAL OF CANCER, 1982, 30 (04) :403-408
[9]   PRESENCE OF CIRCULATING ANTIBODIES AGAINST CELLULAR PROTEIN P53 IN A NOTABLE PROPORTION OF CHILDREN WITH B-CELL LYMPHOMA [J].
DEFROMENTEL, CC ;
MAYLEVIN, F ;
MOURIESSE, H ;
LEMERLE, J ;
CHANDRASEKARAN, K ;
MAY, P .
INTERNATIONAL JOURNAL OF CANCER, 1987, 39 (02) :185-189
[10]  
DIAMANTIS I, 1995, HEPATOLOGY, V22, P774, DOI 10.1016/0270-9139(95)90296-1